Mayo Clinic: Pancreatic Neoplasms trials

The registry lists 36 Pancreatic Neoplasms studies with Mayo Clinic as lead sponsor. 8 are open to participants now and 6 have results posted.

Early Phase 1 1Phase 1 7Phase 2 9Phase 3 2No phase 18(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
• BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic AdenocarcinomaRecruitingNCT07226856Phase 2
• Personalized Education and Genetic Counseling to Increase Genetic Testing in Patients With a Known Family History of Pancreatic CancerEnrolling by invitationNCT06744595Not applicable
• Pancreatic Cancer Detection Consortium (PCDC) Prospective CohortsRecruitingNCT06271291
• A Prospective Registry for Patients at High-Risk for Pancreatic CancerRecruitingNCT06151223
• Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal AdenocarcinomaRecruitingNCT05518903Phase 2
• Intravital Microscopy in Human Solid TumorsRecruitingNCT03823144Not applicable
• Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic DisordersRecruitingNCT00830557
• "Answers in Hours" A Randomized Controlled Trial Using Microbiome Metagenomics for Bile Duct CulturesTerminatedNCT05523154Not applicableResults posted
• Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic CancerTerminatedNCT04975516Phase 2Results posted
• Niraparib and Dostarlimab for the Treatment of Germline or Somatic BRCA1/2 and PALB2 Mutated Metastatic Pancreatic CancerCompletedNCT04493060Phase 2Results posted
• Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 StudyCompletedNCT03033225Phase 2Results posted
• Endoscopic Ultrasound Guided Fine Needle Biopsy (EUS-FNB-SC) Using a Novel Fork NeedleCompletedNCT02678442Not applicableResults posted
• Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic CancerCompletedNCT01015820Not applicableResults posted
• Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic CancerActive, not recruitingNCT06381154Phase 2
• Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal MetastasisActive, not recruitingNCT04858009Phase 2
• Nab-Paclitaxel + Cisplatin + Gemcitabine + TTF in pt. w/ Metastatic PACActive, not recruitingNCT04605913Phase 1/2
• Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerCompletedNCT04067960Early Phase 1
• ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic CancerCompletedNCT04064034Not applicable
• A Study of Photon and Proton Chemoradiotherapy as Definitive or Neoadjuvant Therapy in Non-Metastatic Pancreatic CancerCompletedNCT03902600
• Optical and Biochemical Biomarkers in Early Pancreatic CancerCompletedNCT03404661
• Two Cancers, One Gene. Why Some People in Families Develop Melanoma or Pancreas Cancer, While Still Others Never Develop Cancer.CompletedNCT03174574
• Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic CancerTerminatedNCT02671890Phase 1
• TLR8 Agonist VTX-2337 and Cyclophosphamide in Treating Patients With Metastatic, Persistent, Recurrent, or Progressive Solid TumorsTerminatedNCT02650635Phase 1
• Dignity Therapy/Life Plan in Patients With Pancreatic or Advanced Lung CancerCompletedNCT02132325Not applicable
• Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic CancerCompletedNCT01893294Phase 1
• EUS Guided Celiac NeurolysisCompletedNCT01615653Not applicable
• Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By SurgeryCompletedNCT01537107Phase 1
• Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic NeoplasmsWithdrawnNCT01057355Phase 1
• Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic CancerTerminatedNCT00898781
• Role of CXCR2 Ligands/CXCR2 Biological Axis in Pancreatic CancerCompletedNCT00851955
• Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerCompletedNCT00836992
• Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic CancerCompletedNCT00826982
• Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerCompletedNCT00654160Phase 1
• Vapreotide in Treating Patients Undergoing Elective Pancreatic ResectionTerminatedNCT00014651Phase 3
• Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the PancreasCompletedNCT00003049Phase 3